Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report
Abstract Background Immunocompromised (IC) patients have an increased risk of refractory diarrhea. Fecal microbiota transplantation (FMT) is a safe and effective therapy for infection-related diarrhea which are mainly mediated by the loss of the microbial colonization, although there is concern that...
Main Authors: | Shuwen Zhong, Jingqing Zeng, Zhaohui Deng, Lirong Jiang, Bin Zhang, Kaihua Yang, Wenyu Wang, Tianao Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Italian Journal of Pediatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13052-019-0708-9 |
Similar Items
-
Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial
by: Ye Zhao, et al.
Published: (2021-06-01) -
The clinical features and infectious etiologies of acute diarrhea in immunocompromised hosts
by: Jin Young Lee, et al.
Published: (2017-12-01) -
Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial
by: Liren Qian, et al.
Published: (2020-11-01) -
Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis
by: Shuang Fan, et al.
Published: (2022-08-01) -
Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease
by: Roni Shouval, et al.
Published: (2019-04-01)